Efficacy and Safety of Erenumab, Galcanezumab, and Fremanezumab in the Treatment of Drug-Resistant Chronic Migraine: Experience in Real Clinical Practice.

Published in:

Annals of Pharmacotherapy, 2023, v. 57, n. 4, p. 416, doi. 10.1177/10600280221118402

By:

• Cantarelli, Lorenzo;
• Pestana Grafiña, Diana;
• Gonzalez Perez, Amanda;
• García Gil, Sara;
• Gutiérrez Nicolás, Fernando;
• Ramos Santana, Emma;
• Navarro Dávila, Marco Antonio;
• Otazo Pérez, Sheila María;
• Calzado Gómez, Gloria;
• Perez Reyes, Sergio;
• Nazco Casariego, Gloria Julia

Publication type:

Article